Also trades as: DRUG.CN (CNQ) · $vol 0M
DRUG NASDAQ
Bright Minds Biosciences Inc.
1W: -2.1%
1M: -28.7%
3M: -23.9%
YTD: -39.3%
1Y: -12.5%
3Y: +2990.8%
5Y: +54.5%
$50.69
+1.48 (+3.01%)
Weekly Expected Move ±6.7%
$44
$47
$51
$54
$57
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$14M
-393.8% ▼
Net Income
-$12M
-336.5% ▼
EPS (Diluted)
$-1.78
-173.8% ▼
EBITDA
-$14M
-404.1% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $6M | $12M | $5M | $1M | $11M |
| SG&A Expenses | $2M | $3M | $2M | $1M | $3M |
| Operating Expenses | $9M | $15M | $7M | $3M | $14M |
| Operating Income | -$9M | -$15M | -$7M | -$3M | -$14M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$9M | -$15M | -$7M | -$3M | -$12M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$9M | -$15M | -$7M | -$3M | -$12M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-4.74 | $-6.15 | $-1.98 | $-0.65 | $-1.78 |
| EBITDA | $0 | -$15M | -$7M | $0 | -$14M |
| Shares Outstanding | 2M | 2M | 4M | 4M | 7M |